TrialOrphanet journal of rare diseases2015

A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat.

Tatiana Remenova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.